โก Quick Summary
This article discusses the transformative role of artificial intelligence (AI) in understanding lung immune responses to viral infections. By integrating complex biological data, AI has the potential to predict cytokine storms and acute respiratory distress syndrome (ARDS), paving the way for personalized patient management strategies.
๐ Key Details
- ๐ Focus: Lung immune responses to viral infections
- ๐งฉ Applications: Predicting cytokine storms, ARDS, and patient stratification
- โ๏ธ Methodologies: Single-cell and multi-omics analyses
- ๐ Insights: Distinguishing protective from maladaptive pulmonary immunity
๐ Key Takeaways
- ๐ค AI-driven approaches are revolutionizing our understanding of lung immune responses.
- ๐ฌ Integration of data from imaging, immunology, and laboratory findings enhances predictive capabilities.
- ๐ AI models can predict disease severity and therapeutic responses.
- ๐ก Emerging techniques in drug repurposing and vaccine response prediction are being explored.
- ๐ The study highlights the potential for AI to bridge mechanistic immunology with clinical applications.
- ๐งฌ Molecular signatures can be identified to guide personalized management strategies.
- ๐ Published in: Viruses, 2025.
- ๐ PMID: 41305504.

๐ Background
The field of viral respiratory infections has long grappled with understanding the complex interactions between the host’s immune system and pathogens. Traditional methods often fall short in capturing the dynamic nature of these interactions. With the advent of artificial intelligence, researchers are now equipped to analyze vast amounts of biological data, leading to breakthroughs in predicting immune responses and improving patient outcomes.
๐๏ธ Study
This narrative review synthesizes current evidence on the application of AI in predicting lung immune responses to viral infections. The authors explore various AI-based models that have been developed to assess disease severity, stratify patients, and evaluate therapeutic responses. The study emphasizes the integration of biological complexity with clinical context, showcasing how AI can evolve into a form of translational intelligence.
๐ Results
The review highlights significant advancements in AI methodologies, including the ability to predict cytokine storms and ARDS. By leveraging single-cell and multi-omics analyses, researchers have gained insights into the mechanisms that differentiate protective immunity from maladaptive responses. These findings underscore the potential of AI to enhance our understanding of viral infections and improve clinical decision-making.
๐ Impact and Implications
The implications of this research are profound. By harnessing AI, healthcare professionals can uncover immune signatures that predict antiviral or immunomodulatory efficacy. This capability opens new avenues for personalized management strategies, ultimately leading to better patient outcomes in the face of viral respiratory infections. The integration of AI into clinical practice could significantly enhance our ability to respond to future viral outbreaks.
๐ฎ Conclusion
This review illustrates the remarkable potential of artificial intelligence in transforming our approach to understanding and managing lung immune responses to viral infections. As AI continues to evolve, it promises to bridge the gap between mechanistic insights and clinical applications, paving the way for more effective and personalized healthcare solutions. The future of AI in medicine is bright, and ongoing research in this area is essential for unlocking its full potential.
๐ฌ Your comments
What are your thoughts on the integration of AI in understanding lung immune responses? We would love to hear your insights! ๐ฌ Leave your comments below or connect with us on social media:
Artificial Intelligence for Predicting Lung Immune Responses to Viral Infections: From Mechanistic Insights to Clinical Applications.
Abstract
Artificial intelligence (AI) is increasingly transforming biomedical research and patient care by integrating complex biological, radiological, and healthcare information. In the field of viral respiratory infections, AI-driven approaches have shown great promise in elucidating the complexity of lung immune responses and the dynamic interplay between host and pathogen. Applications include predicting cytokine storm and acute respiratory distress syndrome (ARDS), integrating imaging findings with immunological and laboratory data, and identifying molecular and cellular signatures through single-cell and multi-omics analyses. Similar methodologies have been applied to influenza and respiratory syncytial virus (RSV), providing insights into the mechanisms distinguishing protective from maladaptive pulmonary immunity. This narrative review summarizes current evidence on how AI can evolve into a form of translational intelligence, capable of bridging mechanistic immunology with clinical application. The review explores AI-based models for disease severity prediction, patient stratification, and therapeutic response assessment, as well as emerging approaches in drug repurposing and vaccine response prediction. By integrating biological complexity with clinical context, AI offers new opportunities to uncover immune signatures predictive of antiviral or immunomodulatory efficacy and to guide personalized management strategies.
Author: [‘Tana C’, ‘Soloperto M’, ‘Giuliano G’, ‘Erroi G’, ‘Di Maggio A’, ‘Tortorella C’, ‘Moffa L’]
Journal: Viruses
Citation: Tana C, et al. Artificial Intelligence for Predicting Lung Immune Responses to Viral Infections: From Mechanistic Insights to Clinical Applications. Artificial Intelligence for Predicting Lung Immune Responses to Viral Infections: From Mechanistic Insights to Clinical Applications. 2025; 17:(unknown pages). doi: 10.3390/v17111482